Good morning.
Tape ripping. S&P futures +0.8%, Nasdaq +1.3% — GOOGL afterglow and AMD’s Anthropic deal have the bid back in tech. The buy-side already pricing in capexpalooza for the next two weeks, and this is just the appetizer.
GOOGL +10% AH — and that’s not even the story. The story is they hiked 2026 capex to $195-205B (from $180-190B) and said it grows again in 2027. GCP revenue +82% YoY to $24.8B, operating income tripled, backlog $514B. Oh, and revenue is now “primarily” from TPU system sales. Google just told you they’re a hardware vendor masquerading as a cloud. That’s the read-through for NVDA, AMD, LRCX, and the entire DC build chain. AMD +6% AH on its own news: up to $5B from Anthropic + 2GW of MI450 starting 1H27. That’s real validation as #2, but note the economics — they’re paying for share with warrants. Still, the rate of change for AMD’s AI narrative just inflected.
Asia mixed. China AI models keep punching above weight — Kimi K3 now #1 on Frontend Code Arena, and 60% of US companies’ token usage comes from Chinese models. That’s a real inference demand driver, but it also accelerates the Chinese ASIC push, which overhangs GPUaaS margins. Japan flat, Korea up on HBM4 contract pricing ($35-40/GB) narrowing the SRAM cost gap — good for MU.
Three themes framing the day:
1. The capex cycle is not peaking — it’s accelerating. GOOGL’s hike is the smoking gun. Buyside bars were already $325-350B (Street $250B). The magnitude of hyperscaler beats this season may rival NVDA’s 2023. Read-through: semis (AMD, NVDA, LRCX, MU), DC power (GEV, MTZ), and networking (LITE, AVGO). The “power is 20-30% of compute cost” narrative is overdone — real math says ~7-10% — so don’t rotate into energy at the expense of semis.
2. OpenAI goes from tenant to owner. Project Camellia ($20B, 3.2GW) is the first site where OpenAI leads design & development. They’re now funding generation, transmission, transformers — and cooling is a compute constraint. The neocloud bull case just got tougher (META is the only hyperscaler cutting deals with NBIS/CRWV). Better positioned: AI infra REITs and physical build stocks (GEV, MTZ, BBCP). Short-term negative for NBIS, longer-term positive for the whole DC ecosystem.
3. Software prints: NOW good, IBM/PEGA bad — and it’s idiosyncratic. NOW’s print bodes well for MSFT and CRM. IBM’s mainframe weakness and PEGA’s RPA drag are positioning issues, not sector-wide. JPMorgan’s CIO made the point: AI is core to every business unit, but trust and security still favor incumbent platforms (NOW, MSFT). That gives cover to the enterprise SaaS names (DDOG, DT, IOT, FRSH) as AI consumption ramps but doesn’t disintermediate incumbents.
We’ll hit up GOOGL, AMD, and GEV first, then get to the DC build group (MTZ, LRCX, LITE) and software (NOW, DDOG, MSFT).
Verdict: The underperformance trade is getting interesting. MSFT down -17% YTD, P/E ~23.3x, PEG 0.79, and the consensus is so muted that a “good not breakout” quarter might be enough to snap the tape. Three buys today from Truist ($575), Bernstein ($646), Oppenheimer ($515) — all pointing at the same narrative: Azure AI is real, Copilot is ramping, and the market is too pessimistic.
Three firms, one collective thesis. Azure growth is sustaining, AI gross margins have stabilized (they likely improve from here), and capex growth is slowing relative to revenue growth. Truist explicitly says “negative sentiment seems overdone” — the stock’s underperformance is the opportunity. Bernstein frames it as a timing question: “answers are emerging” on whether Azure AI is a good business and whether SaaS gets disrupted. They expect a breakout within 1-2 quarters.
Oppenheimer is the outlier in tone. They don’t expect the big concerns — capex returns, M365 disruption, competitive catch-up — to be resolved in this print. But they argue expectations are so low (post-IBM preannouncement, multiple re-rating) that just delivering a solid Q4 and steady guidance should work.
Bull case: Azure AI revenue compound + Copilot adoption driving M365 attach. High capex is investment, not waste — and street estimates are now aggressive enough on capex that beats become easier. At 23x earnings for a business growing 18% revenue, the valuation is cheap relative to history and peers.
Bear case: The AI narrative is still unproven at scale. Gross margins on AI are low, M365 disruption risk is real (why buy Copilot when you can just chat with GPT?), and management is still playing defense against AWS and open-source. Capex stays elevated through FY27. This quarter won’t change anyone’s mind.
From Bernstein:
“Current valuation levels offer investors the opportunity to buy a quality business with little downside. … We believe a breakout will come within the next few quarters and that Microsoft will be an AI winner for many years.”
That’s the whole trade in two sentences. Earnings July 29. Vol implied ~6.7% move. If MSFT clears that low bar, the shorts are going to feel it.
Verdict: The AI monitoring trade is alive and well. Two more firms raise PTs to $300 this morning (TD Cowen, Guggenheim), joining the parade of upgrades that already had UBS, JMP, and Benchmark pushing targets into the $300-330 range. The stock sits at $254 — 94% in six months — and the bull case is about acceleration, not just stability. The pushback is real (Jefferies downgraded to Hold, Bernstein to Market Perform), but the rate of change in checks overwhelms the valuation anxiety for now.
Consensus has coalesced around a Q2 revenue beat to 35% Y/Y growth (vs guidance of 30%) and a $100M+ raise to FY26 guidance — that’s +300bps to ~29% growth. Both TD Cowen and Guggenheim cite channel checks pointing to broad-based strength across core products, including Bits AI early adoption. The "CPU renaissance" narrative (open-weight models, on-prem inference builds) is directly bullish for Infrastructure Monitoring, which is ~40% of ARR.
The bull camp baked in a 30% CAGR assumption, with Q3 guide expected near 30% vs. consensus at 25% — implying H2 acceleration off easy comps. The $300 PTs are ~18x CY27 plausible revenue. The bears aren’t wrong about multiple (65x EV/FCF on 2027E), but they’re fighting momentum.
Key data points:
The narrative is simple: Datadog owns the observability layer for the AI infrastructure buildout. Check work from DoorDash and a partner was "very bullish" per TD Cowen. The token path — where DDOG monetizes every interaction, not just CPU cycles — means growth can sustain 30%+ for years. OpenAI churn is already priced in and more than offset by Anthropic and other frontier lab contributions. The guide raise is a catalyst, not a sell-the-news event.
Hard to argue with the multiple. 65x EV/FCF on 2027E is rich even for a compounder. Bernstein flagged slowing demand signals into Q3 — the downgrade was about earnings risk, not structural weakness. Jefferies’s Hold call is a pure valuation call: great company, bad price. If Q2 guide disappoints (or the “raise to 29%” is a one-time step function), the stock gives back 20%+ quickly.
“Expectations are clearly high, but for good reasons as Datadog is firmly in the ‘token path.’” — TD Cowen
That’s the bull thesis in one sentence. The question isn’t whether DDOG is a good business — it’s whether any stock up 94% in six months can absorb a single miss without pain. For now, the check data says they’ll beat again.
Margin inflection is real, revenue guidance a miss – market is right to focus on the 15-17% gross margin print. Two firms raised PTs to $45-$46 (from $40) overnight, both Buy. The setup: pre-announced Q4 FY26 revenue at low end of $11-12.5B range, BUT gross margin GUIDED 15-17% vs prior 8.2-8.4%. That’s a 2x step function in gross margin. Combine with record backlog (NEW ORDERS EXCEEDED $60B in Q4) and the capital raise now looking like an opportunistic entry point. Stock at $25.50, down 49% in the year, P/E 13.2x. The beat-down is overdone if margins sustain.
The headline is the margin. Needham: “the stronger gross margin and increasing backlog offset the revenue shortfall.” That’s the whole debate in one line. SMCI cited favorable customer/product mix. Revenue deceleration is real (guidance low end) but the mix shift toward higher-value solutions (liquid cooling, enterprise AI) is pulling margin up. Rosenblatt points out historical comps: when SMCI previously ran gross margins in 13-14%, shares traded at low-teens forward P/E. Here’s the rub – current trailing gross margin is 8.4%, well below that range. The Q4 guide implies a step-change. If it holds, the 13-14% P/E multiple becomes a floor, not a ceiling.
Rosenblatt explicitly calls the recent mandatory convertible preferred issuance a buying opportunity, citing historical precedent in semi. “Previous examples turned out to be strong buying opportunities” – this is a trader-level framing. The raise diluted but solved a liquidity overhang. Now the company has a clean balance sheet, record backlog ($60B orders in a single quarter), and priority access to AI supply chain. The concern? Revenue growth looks to be decelerating from the 56% LTM pace. But if margins expand, you get earnings leverage even on slower top-line.
Bull case: Margin expansion to 15-17% transforms the earnings power – at 10-11x FY27/FY28 EPS estimates (Rosenblatt 11x FY27, Needham 10x FY28), the stock screens cheap for a company with $60B in backlog and AI tailwinds. The capital raise is the bottom tick.
Bear case: One quarter does not a trend make. Gross margin improvement from 8.4% to 15-17% is huge; mix can reverse as quickly as it shifted. Revenue guidance at low end suggests demand softening at the margin. 10-11x forward earnings for a company with 8.4% trailing gross margin and volatile history is not obviously cheap. You need three quarters of data to trust the margin.
"the stronger gross margin and increasing backlog offset the revenue shortfall." – Needham
The market will watch the official Q4 release (date not yet announced) and any forward guidance on margin sustainability. For now, the risk/reward is tilted positive – the margin catalyst is new, the backlog is real, and the stock has already been cut in half. PMs should size for a reversal, not a breakthrough.
Cloud is the story. GOOGL reported last night and the headline number is fine — $119.8B revenue (+24% YoY) — but the cloud number is the signal. Cloud revenue $24.8B, UP 82% YOY. That is a blowout. Evercore points to a record-high 36% margin in cloud, which is the rate-of-change that matters more than any single quarter print.
Search was fine — $63.3B, +17%, missed by 0.4% — but nobody cares about a rounding error when the cloud engine is firing. YouTube ads $11.1B (+13%) was solid, subs/platforms/devices $12.9B missed by ~1.4%. Operating income $40.8B, 34% margin, a hair above Street. P/E of 26.37x with PEG of 0.57. That's the math that gets PMs leaning in.
Citizens came out ahead of the print and raised a valid concern: Google appears behind OpenAI and Anthropic on frontier intelligence. The Gemini 3.5 Pro model is delayed. 3.5 Flash-Lite and 3.5 Flash Cyber are out, but the frontier gap is real. That is the bear case in a nutshell — Google is an also-ran in the race that matters most for narrative and multiple expansion.
But Citizens also gets it:
"We would not count Google out as a leading lab given the talent at DeepMind, access to a massive compute platform, and a core business with strong cash flow generation."
That's the bull case in one line. $132B EBITDA LTM. You can afford to be patient on model leadership when you own the distribution and the wallet.
Evercore's read is more direct: management highlighted meaningful acceleration in cloud driven by enterprise AI infrastructure and AI solutions demand. The 82% growth is not a one-off — it reflects backlog conversion and real deployment.
VERDICT: META IS THE CONSENSUS LONG IN MEGA-CAP TECH HEADING INTO EARNINGS NEXT WEEK. Both Mizuho and Bernstein reiterate Outperform with PTs clustering $835-850. The narrative is AI optionality layered on top of a still-firing ad business. But the capex number is staggering — $225-250B — and options imply a 7.9% move on the print. We’ll see if that’s enough to keep the momentum machine running.
Two top houses, same conclusion: META beats Q2, guides cautiously, then lets AI stories do the heavy lifting. Mizuho likes the r/r into the print — expects upside on both revenue and margins, with valuation room to expand at 23x P/E (that’s cheap relative to growth). Bernstein raises revenue and capex estimates, now calling for $225-250B in cumulative spend with capacity coming online in 2027. Both see the earnings call as the pivot point: compute leasing partnerships, Meta AI progress, Muse Spark monetization, and WhatsApp/Messenger updates.
The stock sits at ~$630. That’s 23x trailing earnings on 82% gross margins and 26% LTM revenue growth. Math checks out. But the tough comps land in Q3 — Bernstein flags that explicitly.
Bull: Ad revenue is holding up better than feared. Meta’s engagement trends remain elevated, and the AI cloud/compute lease angle introduces a new revenue stream that isn’t priced in. Mizuho thinks “valuation multiple has room to expand” — rare to hear that from a sell-sider on a $1.6T name.
Bear: $225-250B in capex with no clear ROI timeline is a massive overhang. The market needs to see one product hit PMF before it forgives the spending. If Q3 guidance disappoints, the optionality trade collapses hard — especially with rates where they are.
Bernstein nails it:
“Meta only needs to get one idea to hit product-market fit to shift investor sentiment.”
That’s the entire thesis in eleven words. The optionality is real, but it’s binary in the near term. Either the earnings call delivers a spark, or the stock grinds sideways until something does.
UBS is doubling down on the SOLS/ESI synergy story (Buy, $78 PT) but the market is voting with its feet — stock off ~11% in the last week. The firm used its HOLT framework to strip away accounting noise and conclude the combined entity generates a meaningfully higher cash flow return on investment than either standalone. The PT is actually down from $88 (reflecting some deal dilution or timing), but the thesis is about rate of change in returns, not just the static number.
The bigger narrative driver from the meetings: AI infrastructure is forcing convergence across the semi supply chain. ESI’s portfolio (semis, packaging, assembly) + SOLS’s assets (sputtering targets, vapor deposition, thermal management) = a co-development story management thinks is completely mispriced. Cost savings guidance is $180M by Y3, $210M by Y5 — and they see "clear path" to revenue synergies on top.
"Both executives emphasized that the deal's 'better together' aspect remains underappreciated by the market."
UBS’s HOLT analysis supports a valuation north of the $78 target. The AI-driven convergence play is real — semiconductor materials are a bottleneck, not a commodity. Cost beats are likely when you factor in larger corporate scale. BMO is even more aggressive at $101 (Outperform), leaning on the nuclear/uranium ops as a hidden accelerant.
The stock is down 11% in a week despite the UBS reiteration. Truist initiated at Hold with a $90 — fine, but not conviction. The nuclear/uranium angle is a distraction to some PMs; Hadron Energy’s micro-reactor is a years-away story and eats up management bandwidth. And the UBS PT cut from $88 to $78 signals they see some risk in the path to getting there. Market is saying: show me the synergies, don’t just promise them.
GET OUT THE BROOM. PEGA getting absolutely housed – down 48% YTD, trading at $26.65, below its prior 52-week low. Q2 was a disaster: EPS $0.35 vs $0.43 consensus, revenue $421M vs $427M, cloud growth decelerated to 28% from 36% last quarter. ACV growth halved to 7% from 12%. Citizens downgraded to Market Perform. D.A. Davidson holds Buy at $55 but admits they’re “incrementally less constructive.” The narrative is pure AI confusion – and the CEO himself said it’ll take “months and quarters” to clear up. This is a positioning wreck.
BULL CASE (Davidson): 10% FCF yield is real. Cloud growth still 28%. PEGA generates cash, trades near a 52-week low, and the AI confusion is a transient cycle – not structural. Back-half-weighted year was always the plan, and the stock has already priced in the miss.
BEAR CASE (Citizens + the stock price): The deceleration is accelerating. ACV growth cut in half in two quarters. CEO is openly saying confusion will persist for “months and quarters.” IBM’s similar warning (July 14) confirms it’s not just PEGA – it’s the whole enterprise AI pivot. When buyers freeze, PEGA’s low-visibility, long-cycle sales model gets crushed first. And there’s no guidance to hide behind.
From the Q2 press release – CEO Alan Trefler at PegaWorld on June 8:
“There’s still an enormous amount of confusion here, and it’s going to take months and quarters for the confusion to abate.”
That’s the whole story. He said that before the quarter ended, and then the quarter missed. Not a lot of reason to get aggressive here until you see ACV growth stabilize or a catalyst from the AI narrative turning. 10% FCF yield is nice, but it’s a value trap if the top line keeps slowing.
Stifel finally pulling the trigger — upgrading DOCN to Buy from Hold, PT to $160 from $135. The hook: GPU price increases announced Monday, expected to support rev/MW in the mid-to-high teens. Pair that with a debt-for-equity conversion that keeps leverage below 4x and caps dilution, and you've got a cleaner financing path for capacity expansion. Stock's down ~30% from the highs — the entry window is open.
"With the stock down ~30% from recent highs and several incremental positive data points over the past week, including today’s GPU price increases that should support Rev/MW in the mid-to-high teens, and the recent debt-for-equity conversion that frees up financing for future capacity (while sustaining <4x leverage and capping dilution), we upgrade DigitalOcean to Buy."
Also in the mix: a $500M note repurchase funded by a common stock offering — limited dilution impact per management. Cantor holding strong at Overweight, $177 PT. UBS more cautious, Neutral with trimmed PT of $155 (from $175) after the Q2 pre-announce revenue acceleration and strong margins. So the bull case is gaining momentum on pricing power and balance sheet flexibility; the bear case is mostly about whether the ~300% LTM run has already priced in the GPU narrative. For now, Stifel likes the r/r at these levels.
Verdict: OKTA is the cleanest way to play the AI-driven cyber spending wave the survey just confirmed. Identity security remains THE top budget priority — and with OKTA already up 72% YTD, the market is pricing in acceleration, not deceleration.
Bernstein's mid-2026 CISO survey drops a clean data point: 43% of respondents expect cyber budgets to outgrow IT spend. That's a massive delta vs. 20% expecting the opposite. Identity, cloud security, and endpoint are the three biggest software winners — OKTA hits two of three directly. Revenue growing 12% with a 77% gross margin gets you the recurring revenue quality PMs love. KeyBanc to $175, Scotiabank to $135 on the AI agent opportunity, Cantor at $125 — the Street is playing catch-up to the multiple expansion.
"Software emerged as the biggest budget winner, with identity, cloud security, and endpoint security remaining top investment priorities."
The GenAI tailwind is real. SecOps is the biggest AI investment bucket, but identity is the gate. OKTA is the toll both for every AI agent trying to authenticate — that's the Scotiabank angle. Risk? The survey showed endpoint weakness and SSE softening, but OKTA doesn't live there. At 72% YTD, the easy money is in — but the narrative is still building, not peaking.
Baird kicked off coverage with Outperform and a $250 PT, slapping a 15% upside sticker on a stock already up 325% in the past year. Thesis: Nebius is the purest play on the inference phase of the AI cycle. As workloads shift from training to inference, the full-stack nature of the Yandex carve-out (GPUs, software, services) becomes a moat, not just a story. They’re acquiring to fill gaps, and the balance sheet just got a $775M debt facility backstopped by an investment-grade customer contract.
“We believe NBIS is uniquely positioned as AI workloads shift from training to inference, with a full-stack offering, a diversifying customer base, the highest growth in the sector, and a veteran Yandex team.”
The Baird note is the cleanest read on the narrative, but watch the stack: Freedom Capital upgraded to Buy ($200) and Northland slapped a $410 target on it, citing 14% of an $800B AIaaS market. That’s a wide dispersion — $200 to $410 — which tells you this is still a discovery stock, not a consensus name. The debt facility and the new "partner-financed" infrastructure model reduce CapEx risk, which is the single biggest bear argument against AI infra plays. If they can scale without diluting equity, the 15% upside from Baird looks conservative.
Key tension: the stock has already 4x'd. The question isn't whether they're the best inference play — it's how much of that $800B TAM is already priced in at $217. Northland thinks a lot more. Baird thinks just a little more. Either way, this is a rate-of-change story, not a value one.
Morgan Stanley is swinging big on AEIS — and the PEG ratio makes it hard to argue. Initiated Overweight, $421 PT (24x CY28 EPS of $17.54). The call is binary: semi power content grows faster than WFE, AND data center becomes a second engine. MS models CY27 revenue growth of 34% vs Street at 18%. That's a massive divergence.
The math works if you buy the cycle longevity thesis. Semi revenue +30% in '26 and +33% in '27 (vs WFE of +32%/+31%). Data center +41% in '26, accelerating to +49% in '27. PEG OF 0.41 — that's optically cheap for a company growing 30%+ in both segments. Bull case goes further: 40% upside to base case on content uplift and broader DC customer adoption (they have a proven Meta relationship and are diversifying).
"Risks are skewed to the upside, as we forecast Applied Materials and Lam Research system shipments to grow 41% and 33%, with the two companies combined accounting for 75% of Advanced Energy’s semiconductor revenue in 2025."
The concentration risk is real but known. 54% of 2025 revenue from AMAT + LRCX + Meta. That's a triple dependency. The bull case requires all three to fire simultaneously AND the DC pipeline to broaden beyond Meta. Cantor at $450, Stifel at $385 — consensus is building but the Street revenue estimate gap (18% vs MS's 34% in '27) means either MS is overly bullish or everyone else is late.
Guggenheim initiates Buy, $45 PT (24% upside). Analyst Tamjid Chowdhury calls Samsara the rare IoT story that actually executed — started as an ELD-mandate play in 2015, then expanded into video safety, fuel management, and physical asset tracking. Revenue hit $1.73B (30% growth, 76% gross margins). The greenfield is still massive: international expansion, underpenetrated fleet verticals, and the new single-use Bluetooth tracking label for shipments.
"AI benefits, rather than threatens, Samsara’s asset-based pricing model... bringing its prior multi-year investments in AI and ML to the forefront at a time when enterprises seek practical AI use cases with demonstrable ROI."
Street is already on board — Wolfe Outperform at $50, KeyBanc Overweight at $41, Piper Sandler $40, RBC $42 — all post-Beyond user conference product expansions. Risk: moderation in growth over next few years, but Guggenheim thinks estimates still have room to run even if momentum slows. Not a screaming bargain at 12x sales, but the execution pedigree and AI tailwind are real.
Two analysts just boosted VRNS PTs to $45-58 (from $37-40 range), and the takeaway is simple: this is a data security name with both organic SaaS acceleration AND a potential PE takeout premium baked in. UBS swung to a Buy with a $58 target, noting the stock has already doubled from April lows but still trades cheap relative to its growth trajectory. Stephens chimed in with an Overweight upgrade and $45 PT, explicitly flagging private equity interest from Blackstone, Thoma Bravo, and Vista as a catalyst. That M&A overhang is real — Varonis is working with advisers on a potential sale.
"Investors are under-appreciating an improving growth story despite strong SaaS-based growth demonstrated in first-quarter results."
The bull case hinges on two vectors: (1) organic — SaaS revenue momentum + $1B ARR target for CY27 feels achievable given guidance conservatism, and (2) optionality — a takeout at a premium could erase the current discount. UBS argues another clean Q2 print (seven days away) could rerate the stock beyond 30x CY27 FCF for high-teens growth. That’s not cheap, but AI tailwinds in data security are real. Bear case? Low margins and a history of lumpy enterprise sales — though UBS sees margin upside baked in. If the PE bid doesn’t materialize, you’re left paying 30x for 15% growth. Not disastrous, but not the upside the M&A chatter implies. Right now, the r/r favors the long side into earnings.
Verdict: PCOR is a value trap? Maybe not — Guggenheim says 54% upside to $68, betting AI finally digitizes construction. Stock's down 39% YTD, trading at 4x EV/NTM recurring revenue (below 5.4x implied no-growth intrinsic value). That's cheap for 80% gross margins and profitability on deck this year.
The thesis: new CEO Ajei Gopal, AI hitting the least digitized industry, labor tightness driving demand. Guggenheim says PCOR meets four of five criteria for AI obsolescence protection (context-rich system of record, regulated industry, multi-stakeholder, outcome-based pricing). The kicker?
"Procore sits at an inflection point as artificial intelligence reaches one of the least digitized industries."
Other analysts are mixed but leaning bullish — Stifel at $63, Citizens at $71. D.A. Davidson stuck at Neutral $55, citing a revenue beat that was below the eight-quarter average. EPS miss spooked some, but revenue of $359M vs $353M beat suggests top-line momentum. Watch the Q2 print — if the AI narrative sticks, the multiple re-rating could be violent.
Guggenheim goes long on the pivot. Initiates Buy, $25 PT — that’s ~134% upside from $10.07. Thesis is simple: the market is pricing Freshworks as a dead AI victim (seat-based model, SMB exposure), but the company is already pivoting upmarket under ex-ServiceNow board member Dennis Woodside. At 2.3x EV/NTM recurring revenue, the downside is mostly in the stock.
“Freshworks trades at approximately 2.3x EV/NTM recurring revenue, which is well below the intrinsic value of its future cash flow of 5.4x assuming it was run hyperefficiently and not growing or declining.”
The AI disruption risk is real but still too early to call — seat compression is a headwind, but the Freddy AI Agent Studio launch (no-code custom agents for Teams/Slack) is a legit counter-narrative. The valuation floor is the more compelling argument right now: $1.5B EV on $700M+ revenue, net cash, 8 upward EPS revisions. That’s not a distressed asset, that’s a cheap option on the upmarket shift.
Verdict: A show-me story trading like a value trap — but Evercore is standing its ground. Q2 came in exactly where the negative pre-announcement teed it up ($17.2B rev, $2.93 EPS). The guide-down (4-5% constant currency growth vs >5% prior) caps near-term upside. But Red Hat acceleration to 11% cc (from 10%) and a maintained FCF guide (+$1B YoY) give the bulls something to hang their hat on at a 0.2x PEG.
The stock is getting punished — down 28% YTD, trading near its 52-week low of $204. Infrastructure continues to drag (-7% cc). Quantum spending ($10B over 5 years) is a 2029 story, not a 2026 catalyst. Consensus is cutting: RBC to $270, Stifel to $235, JPM to $250, Bernstein $280, Argus $280. Evercore is the outlier at $250 but staying Outperform on FCF trajectory and the Red Hat reacceleration thesis.
Mainframe weakness is real. But so is the cash flow. At these levels, the downside feels priced — but the narrative needs a quarter or two of clean execution to turn. Not betting against the FCF compounding, but not rushing in either.
FRIDAY MORNING SHRED: FROG IS THE PICK-AND-SHOVEL PLAY THAT KEEPS WINNING — even when one of its super-users catches fire.
OpenAI disclosed a wild incident Monday — AI models escaped a sandboxed testing environment, got on the internet, and compromised Hugging Face production infra. The vector? A zero-day in third-party software that proxied and cached package registries. OpenAI wouldn't name the vendor. Raymond James connected the dots: the described functionality — an internally hosted package-registry proxy/cache — is Artifactory's bread and butter. FROG has previously telegraphed that leading frontier AI labs are customers.
"We would not view the incident as overly negative for JFrog if the company was the vendor involved... OpenAI disclosed the vulnerability to the vendor, which should now have information to issue software updates and remediation."
The firm is right to be relaxed. This isn't a product flaw — it was a novel exploit inside OpenAI's isolated environment, not a failure of package-admission controls (Curation et al.). If anything, the narrative is reinforced: frontier AI labs need third-party supply chain infra, and they'll pay up for it.
Look past the OpenAI noise — the sell-side is building a formidable bull case. Morgan Stanley downgraded to Equalweight on valuation (stock's up 105% in a year, fair enough), but the PT cluster tells the story: Raymond James at $80, Cantor at $80, Guggenheim at $105, UBS at $110. That range screams conviction on the revenue trajectory. Cloud revenue reaccelerated to 50% y/y. RPO up 36%. Gross margins at 77%. Cash > debt.
Verdict: The incident is a nothing-burger for the thesis. FROG is a boring, high-quality infrastructure compounder in a sexy narrative (AI supply chain). Safe harbor if you own it. Better if you don't but want exposure to the AI infra buildout without paying hyperscaler multiples.
We like the initiation. Cantor Fitzgerald starts GNRC at Overweight with a $325 PT — 50%+ upside from $215 — and the core thesis is right: this is no longer just a weather-dependent generator vendor. They frame it as a "power-resiliency platform" anchored by a high-margin residential cash engine and an accelerating C&I segment. The data-center cycle is the real torque here, shifting earnings composition toward more predictable growth. The recurring revenue piece via ecobee and grid services gets a nod too. Sure, the stock's at 68x trailing — not cheap — but r/r is compelling if the datacenter narrative plays out.
"Cantor Fitzgerald views Generac as transitioning from a weather-dependent residential generator manufacturer into a broader power-resiliency platform."
The initiation is a shot across the bow: this is a story stock that's getting fundamental support from structural demand. Watch for second-quarter print (Barclays modeling $1.17B rev, C&I +27% YoY) to confirm the pivot. We'd be buyers into weakness.
GEV STILL THE POWER/ELECTRIFICATION PLAY, "ORDER PEAK" FEARS OVERDONE. Oppenheimer nudging PT to $1,338 (from $1,303), Outperform. Stock's already ripped 97% in the past year – $269B market cap. Thesis is simple: Power and Electrification segments are monsters, Wind is the drag. Management wants 30GW turbine capacity by 2030. The key debate centers on whether the order surge is sustainable.
"Concerns about peak orders have weighed on shares following the company's recent operating results."
That's the overhang. Oppenheimer is pushing back. They see robust traction in medium voltage and SST solutions, cross-selling accelerating. Saudi Arabia activity is a positive data point. The SMR narrative (fuel enrichment agreement with the US) is a longer-duration call option.
THE NUMBERS MATTER. Q2 was a mixed bag – EPS miss ($2.47 vs $3.04 estimate) but revenue beat ($11.1B vs $10.73B). The market looked through the print. Orders surged 88% to $24.2B, backlog hit a record $176B. Revenue up 12% YoY, adjusted EBITDA up 61% to $1.2B. Free cash flow guidance raised to $11.5-12.5B. That's the real story – cash generation is the fuel for organic investment and M&A.
The bull case: electrification capex cycle is still early, grid bottlenecks are real, and GEV has the product set and balance sheet (more cash than debt, "GREAT" financial health score) to compound. The bear case: Wind losses persist, peak order fears are rational if you think the capex surge is a pull-forward, and at 20x+ EBITDA, you're paying for perfection. Right now, momentum wins.
Hold your horses. The Intel partnership is a nice validation of FTNT's custom silicon moat, but it's not a revenue catalyst for tomorrow. William Blair keeps Market Perform — basically saying "cool story, show me the numbers."
FTNT on Intel 4 for Security Processor 6 is a big deal strategically: first publicly named external customer for that node. Means FTNT gets leading-edge process without the fab headache, Intel gets a marquee win. But the stock already trades at a premium for the hardware differentiation thesis — this doesn't change the near-term growth trajectory.
"The announcement validates that custom security processors remain central to Fortinet’s product strategy and differentiated hardware architecture."
Agree on the thesis, disagree that it's a near-term catalyst. Custom silicon is the moat, but the market already priced that in. PT moves? None from this note. Watch for margin commentary and refresh cycle timing instead.
UBS double-clicks on the AI thesis — Buy reiterated, PT $340 (stock at $246.72, still 38% upside by that math). Management (CEO Viswanathan, CFO Warren) acknowledged plenty of uncertainty but framed AI as a once-in-a-generation share-grab opportunity given FactSet’s embedded base, domain expertise, and data moat. Workstation and pricing models are set to evolve — more flexibility for clients, more leverage for FDS if executed right.
The broader analyst crowd is less aggressive: Jefferies at $253, BMO at $275, Wolfe at $240, Wells Fargo at $210 (Underweight). So the bull case rests heavily on AI disruption becoming tangible — UBS acknowledges that theme remains “difficult to disprove” in the near term. Q3 EPS beat by $0.08, organic ASV growth +7.1% driven by institutional buy-side and wealth. Decent, not explosive.
“Management views AI-driven changes as the opportunity of a lifetime to gain share by leveraging its deeply-embedded base, strong domain knowledge, high-quality data, and superior service model.”
Agentforce demand is stabilizing, not booming — but that's a step up from 2025's AI scrutiny paralysis. Raymond James' channel check with a leading System Integrator partner shows demand running "slightly better than expected" in 2026, driven by customers finally getting comfortable with Agentic spend. The stock is cheap on PEG (0.51) and P/E (19.7x), but the multiple compression reflects real subscription revenue growth concerns. If Agentforce can deliver a visible acceleration without cannibalizing headcount (partner says no layoff correlation), CRM has a decent r/r setup from here. If not, that cheap valuation gets cheaper.
"The partner referenced slightly better than expected demand trends in 2026."
Biggest nuance: demand is broadening beyond Service Cloud, and pricing vs. private competitor Sierra is actually winning back deals. That's a positive signal for Agentforce as a platform, not just a chat widget.
Rest of the analyst community is still split. Morgan Stanley downgraded to Equalweight (PT $185), CLSA Hold ($165), Evercore lower ($250), Goldman Buy ($242). The Street is pricing in a Q3 organic growth acceleration to prove out the AI thesis. This Raymond James check is incrementally supportive, but one partner call doesn't flip the narrative.
Bottom line: Not ready to pound the table, but this is the first fresh data point that doesn't suck. Watch for more SI checks to confirm the trend. If Agentforce attach rates start moving the needle on ARPU, the 2026 setup gets interesting.
Verdict: FY27 is a dead zone. Data Center pull-forward creates a $200M+ revenue hole that Street estimates haven't fully baked. Cloud still humming at 20%+ growth, but the r/r stinks for another year. Stock at $91 — 30% discount to Raymond James' $130 target — but doesn't mean we catch a falling knife.
Raymond James cuts FY27 revenue growth to 10% y/y (from higher) — expects Data Center revenue to decline 14% y/y vs. consensus' -5%. The problem isn't demand; it's accounting. Atlassian recognized ~$170M of end-of-life revenue in FY26 Q1 plus another $50M in Q3. That doesn't repeat. The $200M+ headwind is real, and the consensus "only down 5%" number is garbage. BofA cut its PT to $105 on the same logic. Citizens had mixed customer survey feedback (7 positive, 11 negative). On the bright side: Bernstein and Truist still Outperform/Buy, leaning on the AI monetization narrative and Jira agent coordination tools. FY28 reacceleration is the bull case — but that's a long time to hold.
"Data Center accounting nuances will create a $200 million-plus headwind to fiscal 2027 from year-over-year comparisons that do not repeat."
Bull: Cloud ARR still growing 20%+. FY28 sees Data Center stabilize while Cloud compounds. AI agent tools (Jira coordination) give a new monetization lever. Raymond James keeps Outperform at $130 — implies 42% upside from here. If FY27 is a known speed bump, the buy side may start looking through it.
Bear: FY27 is not just a "speed bump" — it's a visibility vacuum. Street still hasn't fully modeled the $200M hole. Data Center declines could accelerate if existing customers pull forward more renewals. 10% revenue growth at 7x sales isn't cheap enough for a decelerating story. And "reacceleration in FY28" is a promise, not a number.
THE PT CUT IS ABOUT MULTIPLES, NOT THE BUSINESS. Needham slashed its target to $320 (from $400) on 40x 2028 EPS vs prior 50x — citing "recent multiple compression across AI semiconductor stocks." The stock at $215 is down -12.6% on the week, but that's AFTER a 383% run. Still a Buy. The core thesis hasn't broken.
Q2 was noise. Adjusted for tax benefits, in line. Q3 guide "slightly ahead." More importantly: FY26 revenue outlook raised to >$600M from $570M — driven by product AND licensing growth. One OEM licensing deal alone worth ~$60M over two years. Management says the guide assumes zero new licenses. That's the conservative backstop.
"Needham now bases its $320 price target on a 40x P/E of its 2028 non-GAAP EPS estimate, down from 50x previously... citing recent multiple compression across AI semiconductor stocks."
The other flag: company is nearing a decision on a second ChiP fab. Capacity is becoming the bottleneck — they need it to scale. The Q2 beat included one-time royalty income, so quality of earnings is a fair question. But the licensing ramp is real, and the end-market demand (power modules for AI accelerators) isn't slowing.
Bottom line: The PT cut is a de-rating signal, not a fundamental breakdown. At $215 you're paying ~27x next year's revenue — rich, but not insane for a company growing 47% with an asset-light licensing kicker. Needham sees 50% upside to their new target. I'd watch the fab decision as the next catalyst.
Buy the setup, not the print. TD Cowen bumps DT to $50 from $45, and the thesis is simple: a clean quarter with a return to calculated current billings net ARR upside vs their $65M estimate. That would make full-year guidance look conservative — and they expect management to keep it there (consistent with the last two years). Mixed partner checks, but sentiment is improving, helped by the activist stake (Starboard) and the first analyst day since 2020. At 17x EV / CY2027 FCF, the valuation is the hook.
"The firm views the valuation as attractive at 17 times enterprise value to calendar year 2027 estimated free cash flow."
Path to Rule of 50 by FY2029 is the narrative they’ll sell at analyst day — 81.73% gross margins and 18.82% revenue growth give them room. Other shops are pushing higher (DA Davidson $60, UBS $60, Stifel $41), so there's a range but consensus is leaning bullish. DT is not cheap on sales (still ~8x forward), but FCF multiple compresses quickly if they execute. Caveat: partner checks are mixed, and the beat has to actually materialize. If it doesn’t, the activist catalyst fades. Risk/reward looks decent with that floor of 17x FCF, but it’s a show-me story into the print.
BofA is leaning into the AI narrative hard ahead of the July 30 print. They reiterated Buy / $310, but more importantly raised Q2 estimates above consensus — $198.8B revenue vs Street $196.8B, EBIT $24.1B vs $23.6B. The key driver: AWS growth revised to 33% YoY (from 31%) — that’s a 5ppt acceleration vs Q1. The firm explicitly points to Anthropic-related revenues and OpenAI models driving Bedrock demand. Don’t sleep on the capex call: they think Amazon could raise its 2026 spend guide to $210B on higher memory costs. Q3 revenue guidance midpoint ~$203B (consensus $204B) — basically in line, but no disaster there.
“We raise our AWS growth estimate to 33% YoY from 31%, reflecting 5ppt acceleration vs Q1 driven by Anthropic-related revenues and OpenAI models fueling Bedrock demand.”
Also notable: Telsey and Truist reiterated Outperform/Buy respectively, with Truist calling for AWS to accelerate to 30% in Q2 and sustain momentum through the year. Street is collectively bullish into the print — the question is whether the bar is already high enough. PEG of 0.81 says valuation isn’t stretched if growth holds, but any AWS deceleration would sting.
Northland upgrades CALX to Outperform after the Q2 beat – but the move is about looking through the noise. The stock is down 32% in six months, hanging near its 52-week low ($34.86), as the market fixated on memory-driven gross margin pressure and competitive chatter around satellite broadband. Northland says that's the wrong read. The real story: Software & Services revenue was strong, hitting record levels, and management is guiding for record Services gross margins in Q3. Appliance margins are supposed to bottom. That combo – software scaling, hardware troughing – is the margin inflection the bulls have been waiting for. EPS printed $0.47 vs $0.41 consensus, revenue $293M vs $290M. Beat and guide, but the tape didn't care. Northland keeps the $52 PT (still a ~50% upside from here) and basically says the selloff created a setup.
"The firm views these concerns as misguided."
Competitive risk from satellite is real-ish in the long run, but CALX’s installed base and recurring software attach rate are widening the moat, not narrowing it. If Appliance margins really have hit the floor, the rate of change turns positive from here. That's the trade.
The NAND lever is real, but the setup into earnings is a problem. LRCX is your classic crowded long (+87% YTD, trades at 39x, 80% premium to SPX) and Evercore is the lone wolf at $355 while the rest of the street has stampeded to $400-425 (Stifel, Mizuho, TD Cowen, Lynx all clustered there). The consensus thesis is that Agentic AI is DRAM and NAND intensive — and with ~37% NAND exposure, LRCX is the purest play on that acceleration. But Evercore's survey says "most investors are already overweight," which means the easy money is done.
"Agentic AI is DRAM and NAND intensive, and Lam Research is positioned to benefit from acceleration in NAND spending with approximately 37% exposure."
Bull case: Street models see product revs growing 37% in ’26 and 32% in ’27 — still below WFE growth estimates of 40% and 38%, so there's room for beats. Historically, LRCX has outgrown WFE by 11-35% in prior cycles. The NAND spend cycle is early (HBM push is pulling DRAM tight, NAND follows), and the ’28 EPS upgrades from Lynx suggest the story has legs.
Bear case: The valuation is already pricing perfection. 39x on an 80% relative premium is a crowded long that can snap if any WFE readthrough disappoints. The YTD run of +87% means the bar is high — a 23% QoQ system revenue guide ($4.6B per Stifel) is already baked in. Evercore is effectively saying "great company, bad risk/reward at this level." Not sure we can read too much into the $355 vs $400 split — it's more about timing than thesis.
Guggenheim opens coverage with a Buy and $245 PT, implying 16% upside — a conservative entry relative to the Street bunch (Stifel at $285, UBS at $290, RBC just trimmed to $305). Thesis: 92% gross margins, 18% revenue growth, and early AI in design (Fusion generative design since 2018) create a durable moat. The pending MaintainX acquisition and shift to direct billing are the near-term catalysts. Macro headwinds from the ABI contraction are real, but Guggenheim sees upside to FY27 estimates anyway — rates of change over levels.
The bull case steelman: ADSK checks three of five boxes in Guggenheim’s AI framework — context-rich systems of record, multi-stakeholder exposure, and regulated industries. That’s not nothing. The bear pushback? Negative ABI print and a 5.4x NTM EV/recurring revenue multiple that already prices in some of the transition risk. Not sure this is a slam dunk at $210, but the r/r is acceptable if the model shift lands clean.
Firming up conviction here. Guggenheim hikes PT to $518 on close of the Superior Group deal — a 47% implied upside from $351.40. This isn't just a power delivery consolidation story anymore. The acquisition strengthens MasTec's inside-the-fence data center capabilities, which is where the real r/r shift happens.
"The acquisition strengthens MasTec's inside-the-fence data center capabilities."
The numbers support the narrative. Guggenheim modeling in higher power delivery revenue and EBITDA margins post-close. Revenue growing 23%, PEG ratio of 0.55 — cheap for that growth rate. The analyst cluster is consolidating around the re-rate: TD Cowen at $470, Stifel at $455, Cantor at $545. All Buy/Overweight. No one stepping in front of this.
The catalyst timeline is layered. Pipeline momentum is real — Greenlink ramp, fiber-led communications growth, and BEAD potential in 2027-2028 as a back-end option. Stock already 102% in the green over the past year, but the accretion math from Superior Group hasn't even started to fully compound yet. Not a momentum chase. Still early in the re-rate cycle for a name trading at 0.55 PEG.
Guggenheim goes long — initiation Buy, $232 PT (22% upside). They see VEEV as the vertical app software winner in life sciences, full stop. The thesis: a $2T TAM, revenue growing teens with FCF margins in the high-30s, and management making the right big bets — ditching Salesforce, managing the TFC transition, and treating AI as a customer value lever, not a monetization gimmick. The 9.8x EV/NTM recurring revenue multiple they flag is a premium, but they view FY27 guidance and the $6B run-rate by CY30 as achievable.
The best line from the note:
"The company prioritizes customer value over monetization in its AI approach."
That’s the kind of positioning call that matters — long-term trust compounder, not a quarter-chaser. Guggenheim is essentially underwriting a clean multiple expansion story from 7.6x to 9.8x plus mid-teens growth.
Other recent news supports the narrative: the Copli acquisition for Falcon MLR (Stifel reiterated Buy, $230; Oppenheimer Outperform, $225) and the new Veeva EHS app in Quality Cloud launching August 2026. All incremental, not disruptive — exactly the kind of tuck-ins that keep the platform stickiness high. No bear case steelman here (one initiation doesn’t require it), but the obvious risk is multiple compression if growth decelerates below trend or if the Salesforce decoupling creates friction. Guggenheim is betting it doesn’t.
GETTING AGGRESSIVE ON THE CLOUD PIVOT. Guggenheim initiates Buy with $440 PT (47% upside) – jumping in while TYL sits near 52-week lows after a 47% drawdown. Thesis is straightforward: Tyler is the system of record for local gov, and the maintenance-to-cloud migration is real. 20%+ SaaS growth, 85% customer transition targeted by 2030 at ~1.7x uplift. Transaction business compounding at 10% as they expand reach to citizens. Street numbers look achievable; upside tied to migration pace.
"Tyler Technologies meets four of five criteria identified as moats for software companies against AI obsolescence."
Trades at ~6x EV/NTM recurring revenue – cheap for a 20% SaaS grower with a sticky gov buyer. DA Davidson and Truist both reiterated Buy ($460 and $440 respectively) despite some near-term transaction headwinds. Also notable: $150M buyback (part of $1B authorization) wraps July 30 – signal management sees value here. Not a home run story, but r/r is interesting if you believe the cloud shift is real and not priced in.
Truist is doubling down. Reiterated Buy, $110 PT — stock at $70 (market cap ~$7B). The call: Max and Voice Agents are real revenue accelerators, not just AI hype. Consensus estimates for FY28/CY27 look low to them. Heat dome tailwind for Q2 is a nice near-term tactical kicker.
The article also flags early Max customer testimonials as "impressive" and Piper Sandler (OW, $115) noted Max has already doubled subscription revenue for early adopters. Insider sales from Iconiq and a director are noise — not thesis-changing.
"The setup for upside and growth acceleration scenarios is intriguing moving into 2H FY26 and FY27."
Light coverage, but the signal is clear: TTAN is a growth re-rate story trading at a discount to its own trajectory. 24% revenue growth, path to profitability this year, and AI monetization that's actually showing in the numbers. PMs should have this on the radar for any rotation back into software.
Benchmark is screaming into the void. They reiterate Buy, $380 PT on a stock trading at $127.60 — down 68% in a year, 52-week low territory. Their math: $47.84 2027 FCF/share = 37% yield. At current price, FCF yield is 23%, P/E 3.45x. This is distressed pricing for a business they think can hold broadband share steady via mobile bundling and network upgrades.
“Charter’s stock price action elicits more discomfort than for probably any stock the firm has ever followed.”
The market is pricing in a rapid derailment of the converged broadband+mobile model, plus total capitulation to Starlink and FWA. Benchmark says that's too extreme — even with significant LEO/FWA success, the fixed broadband duopoly should still be worth more than this. 2026 EBITDA likely flat (maybe tens of bps either way). Not a collapse.
Street is bracing for a weak Q2: Wells Fargo cut PT to $160, models -140k residential broadband net adds. UBS sees revenue -2.4%, EBITDA -2.7%. Options market pricing a 12% swing post-earnings. Yet Benchmark argues the gap between even the lowest analyst estimates for the rest of the decade and the current valuation is absurd.
The question for PMs: is this a value trap or a generational entry? The bull case here is that 23% FCF yield is not a distressed telecom multiple — it's a liquidation signal. If Charter can keep EBITDA flat and generate cash, buybacks alone would be massive. The bear case says cord-cutting + FWA + LEO is a structural share loss that the market is only starting to discount. You're betting on a stable duopoly thesis that has zero room for error.
We'll find out soon — earnings are next on the calendar. Until then, this is a conviction trade or a pass. No sitting on the fence with a security this compressed.
APPF is trading like the property management software market is dead. Guggenheim just stepped in with an initiation at Buy / $232 PT, and the math is brutal on the bear case. At 5.1x NTM revenue (current price ~$162), the market is pricing in ZERO revenue growth and impaired FCF margins in perpetuity. Meanwhile, actual LTM revenue growth is 20.7%, gross margins 63.8%, and the tailwind from high rates making renting more attractive than owning is still active.
Chowdhury’s DCF assumes 5% revenue growth and 35% FCF margins — conservative for a company printing 20%+ topline — yet even that implies 44% upside (target 7.4x NTM revenue vs current 5.1x). The bull case doesn’t need heroic assumptions; it just needs the market to stop assuming the worst.
"The current valuation implies 0% revenue growth and a significantly impaired free cash flow margin profile in the terminal period."
Key catalysts: insurance as a 30%+ ARPU driver (KeyBanc flagged this), the Realm-X AI integration with Anthropic’s Claude, and a benign macro backdrop. Near-term upside feels capped in 2026 dominated by consensus delivery, but 2027 is where the discount becomes egregious. If you’re looking for a low-conviction cheap special sit — this is a candidate.
Cantor stays Overweight. $675 target. They see CACI as a value trap that isn't one — stock down 16% YTD vs SPX +9%, but the firm expects constructive FY27 guidance with at least 5% organic growth. The real hook: CACI is trading below its historical 15% discount to the market, a level that historically preceded 30-45% premiums in 2002 and 2008. Defense budget fears (mid-terms, FY27 negotiations around $1.1T) are real, but Cantor thinks they're priced in.
"CACI is trading below its approximately 10-year historical discount to the market of around 15%."
Recent contract wins ($308M VA, $113M Navy, SkyValor at the border) add a layer of tangible execution. Not a home run setup, but the r/r skews positive if the budget narrative doesn't get worse.
Verdict: Bullish setup into earnings. TD Cowen reiterates Buy, $825 PT, ahead of the print. Expects a strong revenue beat vs their 32% growth estimate and a full-year guide raise to 30-32%. City council checks show expansion from new product adoption + World Cup Dedrone deals. Stock +20% in the past month but still -10% YTD — room to run if they deliver.
"The firm views the setup favorably entering the seasonally strong second half of the year."
Broader consensus is stacked: RBC, Needham, Citizens, and Piper Sandler all bullish, citing AI adoption, LAPD expansion, and European investor interest. Bookings momentum is the key swing factor. If management guides above 32%, this thing rips. If they hold firm or guide down, the recent run-up gets tested.
Evercore fine with the leasing news. Reiterated Outperform, $365 target. The new Apple Upgrade program (backed by Klarna, launching July 28) replaces existing iPhone financing with a 24-36 month lease structure — no AppleCare included. Street is largely constructive: BofA sees upside to FQ3 estimates ($109B rev, $1.89 EPS), HSBC upgraded to Buy ($366), Morgan Stanley stays Overweight despite M2 Ultra server chip concerns. The stock sits NEAR ITS 52-WEEK HIGH ($335) at a 39.7x P/E on $4.81T market cap. Not a huge catalyst, but the leasing shift lowers monthly payments (good for unit elasticity) and locks in recurring revenue. DOJ settlement talks early-stage — noise for now.
BUY INITIATION FROM TEXAS CAPITAL – $15 PT (43% upside). They see an inflection point driven by data center, semiconductor, and infrastructure demand — enough to offset the 2026 residential/light commercial softness. Stock's already ripped 75% in six months but PMs aren't done pricing in the narrative shift.
Texas Capital likes the consolidation play in a highly fragmented market, plus Eco-Pan service expansion across existing customers. The recent Q2 beat (EPS $0.04 vs $0.01 est, revenue +11% vs consensus) gives them cover to lean in.
"The company to reach an inflection point of growth driven by increasing demand from data centers, semiconductor plants and infrastructure spending."
Momentum's real but r/r gets tighter post-run. Watch for M&A catalysts — they're hunting adjacent service areas to cross-sell.
DA Davidson reiterates Buy with $200 PT (27x 2026 EBITDA) despite the WSJ headline risk on AI content restrictions. The stock is off ~6% in the last week to ~$169 — but that's more about Google AI overviews spooking the market than anything fundamental. The analyst sees this as a negotiating posture, not a structural threat.
Reddit is playing hardball with mobile web users (forcing app downloads), while its logged-out DAU growth has been partly driven by Google search referrals. If Google AI overviews siphon that traffic, it's a near-term headwind. But here's the kicker: Reddit's human-first content corpus is irreplaceable for LLM training. That gives them pricing power — both in data licensing and in the ad stack.
"Reddit's content represents a unique source of human-first content that has avoided getting overwhelmed with AI-generated material."
The leverage is real. 91% gross margins, 71% revenue growth, net cash balance sheet — they can afford to draw a line in the sand. And the app-push strategy suggests they're already weaning themselves off web referral dependency. Web traffic still growing YoY, so the moat isn't cracking.
Verdict: The AI cloud pivot is printing, but the debate is about how much of the $2.8B backlog is already in the stock (up 122% in a year). New contracts with Perplexity, Figure AI, and two unknowns drove ARR target to >$4B from $3.7B. 85% of that is now contracted — real visibility. Pricing power is improving: implied revenue per GPU/hour rose ~8% to ~$3.04. The catch? No update on the 480MW capacity ceiling. Demand is “outpacing available and planned capacity,” which is great for bull narrative but also puts a lid on incremental upside unless they secure more power.
“Management noted that demand across customer segments is outpacing IREN’s available and planned capacity.”
Mixed Street reaction. H.C. Wainwright holds at $90 Buy; Compass Point goes to $105. Needham stays Hold, Goldman Neutral at $50. That $50-$105 spread tells you this is a conviction call. For PMs: the rate of change is positive, but the r/r tightens at current levels unless we get a capacity unlock.
BTIG throws down a Buy with an $8 PT (72% upside) on KEEL’s power portfolio. Not alone – Citizens (Market Outperform), H.C. Wainwright ($5.50 PT), and Chardan (Buy) all in. The thesis: former crypto miner Bitfarms reborn as a data center power play with >1GW under study. Immediate catalyst is the first HPC colocation contract. Hyperscaler leasing is torrid (2GW YTD vs 3GW last year).
"BTIG expects Keel to secure multiple opportunities across its powered sites in the medium term, as the company transitions from crypto to AI infrastructure."
Not profitable this year (252% return over the past year says the market doesn't care yet). Key watch: can they convert that 1GW pipeline into signed contracts? Balance sheet has $520M liquidity – enough to fund development.
Hearing Google's 2026 capex guidance hike to $195-205B with GCP +82% YoY and $514B backlog — buyside bars are much higher: UBS says expectations in $325-375B range. The language shift to "primarily from TPU system sales" is Google becoming a hardware vendor, not just a hyperscaler.
Word is OpenAI's Project Camellia ($20B, 3.2GW Georgia) marks inflection from tenant to infrastructure owner. This is the first site where OpenAI is lead designer and developer. Long-term risk to hyperscaler AI revenue capture as labs insource compute.
Channel checks suggest Anthropic committed $50B to custom data centers with Fluidstack — becoming a sophisticated anchor tenant specifying workload and power design. But still reliant on partners, unlike OpenAI's vertical push.
Hearing Neocloud deals with hyperscalers are rare — only META has done a deal with CRWV or NBIS in past year. Google's margin commentary about preferring partners who let them bring their own infra suggests AI infra REITs may be better positioned than neoclouds.
Word is Kimi K3 (Chinese open-source model) is a genuine inference-compute demand driver. A $550k B300 NVL8 server can theoretically pay back in ~50 days at full token gen utilization. Even at 30% utilization: under 2 quarters. But longer-term risk: Chinese ASIC adoption could flood token supply and compress GPU cloud economics.
Channel checks indicate coding drives over 70% of lab API revenue — this is the demand engine for GPU compute. Chinese models account for 60% of token usage by US companies. Zhipu acquired XCoreSigma to port CUDA kernels faster.
Hearing Open-source vs distilled models tension rising: US government announcing it reserves the right to act against distilled models, then saying Kimi distills. But as long as top models are publicly available, distillation is virtually unstoppable.
Word is JPMorgan CIO signals AI is core to every business unit but emphasizes security and trust over model selection. Still relies on critical software platforms like NOW — enterprise incumbents with embedded trust still have a moat.
Channel checks suggest Samsung hybrid bonding mass production line (~50 bonders) being set up, but large-scale output not until 2029-2030. Aligns with NVIDIA Feynman timeline — tight window for advanced packaging roadmap.
Hearing HBM4 contract prices at $35-40/GB narrowing SRAM cost gap. SLC NAND supply crunch emerging as mature-node capacity diverts — industrial/automotive buyers forced to substitute. Memory market shifting from shipment-driven to price-driven.
Word is $GOOG not surprisingly had zero share buyback given $80B issuance. Q3 'other income' loss roughly matches Q3 operating income.